Covered recipient · General Payments record
KELLY A GOODMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,593.86
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $409.94 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $166.07 | 9 |
| Stryker Corporation | $61.12 | 1 |
| Galderma Laboratories, L.P. | $39.15 | 2 |
| REVANCE THERAPEUTICS, INC. | $28.00 | 1 |
| Axsome Therapeutics, Inc. | $26.37 | 1 |
| Supernus Pharmaceuticals, Inc. | $25.33 | 1 |
| Novo Nordisk AS | $21.76 | 1 |
| Acerta Pharma LLC | $21.65 | 1 |
| PFIZER INC. | $20.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.84 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237250 | CMS |
| ABBVIE INC. | $7.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237252 | CMS |
| ABBVIE INC. | $23.67 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237254 | CMS |
| ABBVIE INC. | $18.72 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237256 | CMS |
| ABBVIE INC. | $22.30 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237258 | CMS |
| ABBVIE INC. | $4.01 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237260 | CMS |
| ABBVIE INC. | $24.01 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237262 | CMS |
| ABBVIE INC. | $22.10 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237264 | CMS |
| ABBVIE INC. | $22.51 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107237266 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.65 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104251535 | CMS |
| Axsome Therapeutics, Inc. | $26.37 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148377320 | CMS |
| Galderma Laboratories, L.P. | $20.45 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145360347 | CMS |
| Galderma Laboratories, L.P. | $18.70 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145360349 | CMS |
| Novo Nordisk Inc | $21.76 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100265002 | CMS |
| PFIZER INC. | $20.49 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131199998 | CMS |
| REVANCE THERAPEUTICS, INC. | $28.00 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147940638 | CMS |
| Stryker Corporation | $61.12 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120032337 | CMS |
| Supernus Pharmaceuticals, Inc. | $25.33 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147900048 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.